Cargando…
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by both motor and non-motor symptoms. Gastrointestinal tract dysfunction is one of the non-motor features, where constipation is reported as the most common gastrointestinal symptom. Aromatic bacterial met...
Autores principales: | van Kessel, Sebastiaan P., de Jong, Hiltje R., Winkel, Simon L., van Leeuwen, Sander S., Nelemans, Sieger A., Permentier, Hjalmar, Keshavarzian, Ali, El Aidy, Sahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574542/ https://www.ncbi.nlm.nih.gov/pubmed/33076930 http://dx.doi.org/10.1186/s12915-020-00876-3 |
Ejemplares similares
-
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019) -
Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019) -
Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019) -
Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2021) -
Stability of Methylphenidate under Various pH Conditions in the Presence or Absence of Gut Microbiota
por: Aresti-Sanz, Julia, et al.
Publicado: (2021)